On Invalid Date, Cns Pharmaceuticals (NASDAQ: CNSP) reported Q3 2023 earnings per share (EPS) of -$1.08, up 57.81% year over year. Total Cns Pharmaceuticals earnings for the quarter were -$4.52 million. In the same quarter last year, Cns Pharmaceuticals's earnings per share (EPS) was -$2.56.
As of Q1 2024, Cns Pharmaceuticals's earnings has grown year over year. Cns Pharmaceuticals's earnings in the past year totalled -$18.98 million.
What is CNSP's earnings date?
Cns Pharmaceuticals's earnings date is Invalid Date. Add CNSP to your watchlist to be reminded of CNSP's next earnings announcement.
What was CNSP's revenue last quarter?
On Invalid Date, Cns Pharmaceuticals (NASDAQ: CNSP) reported Q3 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Cns Pharmaceuticals's revenue was $0.00.
What was CNSP's revenue growth in the past year?
As of Q1 2024, Cns Pharmaceuticals's revenue has grown null year over year. Cns Pharmaceuticals's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.